Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

373 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder.
Baras AS, Drake C, Liu JJ, Gandhi N, Kates M, Hoque MO, Meeker A, Hahn N, Taube JM, Schoenberg MP, Netto G, Bivalacqua TJ. Baras AS, et al. Among authors: kates m. Oncoimmunology. 2016 Feb 18;5(5):e1134412. doi: 10.1080/2162402X.2015.1134412. eCollection 2016 May. Oncoimmunology. 2016. PMID: 27467953 Free PMC article.
Tissue-engineered urinary conduits.
Kates M, Singh A, Matsui H, Steinberg GD, Smith ND, Schoenberg MP, Bivalacqua TJ. Kates M, et al. Curr Urol Rep. 2015 Mar;16(3):8. doi: 10.1007/s11934-015-0480-3. Curr Urol Rep. 2015. PMID: 25677229 Review.
Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes.
Gandhi NM, Baras A, Munari E, Faraj S, Reis LO, Liu JJ, Kates M, Hoque MO, Berman D, Hahn NM, Eisenberger M, Netto GJ, Schoenberg MP, Bivalacqua TJ. Gandhi NM, et al. Among authors: kates m. Urol Oncol. 2015 May;33(5):204.e1-7. doi: 10.1016/j.urolonc.2015.02.011. Epub 2015 Mar 23. Urol Oncol. 2015. PMID: 25814145 Free PMC article.
Sickle Cell Disease in Priapism: Disparity in Care?
Joice GA, Kates M, Sopko NA, Hannan JL, Bivalacqua TJ. Joice GA, et al. Among authors: kates m. Urology. 2015 Jul;86(1):72-7. doi: 10.1016/j.urology.2015.01.050. Urology. 2015. PMID: 26142586
Reply: To PMID 26142586.
Joice GA, Kates M, Bivalacqua TJ. Joice GA, et al. Among authors: kates m. Urology. 2015 Jul;86(1):78-9. doi: 10.1016/j.urology.2015.01.052. Urology. 2015. PMID: 26142587 No abstract available.
Validation of a frailty index in patients undergoing curative surgery for urologic malignancy and comparison with other risk stratification tools.
Lascano D, Pak JS, Kates M, Finkelstein JB, Silva M, Hagen E, RoyChoudhury A, Bivalacqua TJ, DeCastro GJ, Benson MC, McKiernan JM. Lascano D, et al. Among authors: kates m. Urol Oncol. 2015 Oct;33(10):426.e1-12. doi: 10.1016/j.urolonc.2015.06.002. Epub 2015 Jul 9. Urol Oncol. 2015. PMID: 26163940 Free PMC article.
Use of regenerative tissue for urinary diversion.
Sopko NA, Kates M, Bivalacqua TJ. Sopko NA, et al. Among authors: kates m. Curr Opin Urol. 2015 Nov;25(6):578-85. doi: 10.1097/MOU.0000000000000223. Curr Opin Urol. 2015. PMID: 26383039 Review.
373 results